Effective dose of IV dexmedetomidine for prolonging the duration of analgesia after single-shot femoral nerve block with ropivacaine for knee surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002210

Enrollment

Registered

2017-02-03

Start date

2016-10-19

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : All of the patients under knee surgery receive single shot femoral nerve block for postoperative pain control. after nerve block, we conduct general anesthesia. after general anesthesia inducti

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Unilateral surgical femoral nerve block procedures under general anesthesia -American Society of Anesthesiologist classification I-III patients -Age>18years

Exclusion criteria

Exclusion criteria: -American society of anesthesiologist classification IV or V patients -Age<18years - pregnancy -coagulopathy -unstable coronary artery disease, congestive heart failure, arrythmia, cardiomyopathy -Known cerebrovascular disease -generalized infection, infection at skin femoral nerve block -chronic pain disorder -severe pulmonary neurologic deficits, neuropathy affecting limb -refusal -local anesthetics allery psychiatric>

Design outcomes

Primary

Measure	Time frame
Duration of interscalene nerve block	—

Secondary

Measure	Time frame
opioid consumption ;pain score ;duration of motor blockade ;side effects to dexmedetomidine(bradycardia, temporary hypotension, sedation)	—

Countries

Korea, Republic of

Contacts

Public ContactRYUNGA KANG

Samsung Medical Center

ryunga.kang@gmail.com+82-2-3410-2470

Outcome results